Skip to content
lifestyle.washingtonguardian.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NEKTAR THERAPEUTICS
Nektar Therapeutics to Participate in Two Investor Conferences in March
February 24, 2026
Nektar Therapeutics Announces Research Collaboration with UCSF and Dr. Stephen Hauser for NKTR-0165, a Tumor Necrosis Factor Receptor 2 (TNFR2) Antibody, in Multiple Sclerosis
February 17, 2026
Nektar Therapeutics Announces Proposed Public Offering
February 12, 2026
←
Previous Page
1
2
3